C12N 2710/10031
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2710/10031 (Uses of virus other than therapeutic or vaccine) appears on 5 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 11
- Assignees
- 5
- Inventors
- 19
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 3 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of treating dementia associated with alzheimer's disease with protective protein/cathepsin A (PPCA)26 May 2026US 12,640,251 B2St. Jude Children?S Research Hospital
- Nanocomposite matertail1 Aug 2023US 11,713,444 B2Cellucomp Limited
- Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)14 Jan 2020US 10,533,208 B2St. Jude Children?S Research Hospital
- Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use12 Dec 2017US 9,840,727 B2St. Jude Children?S Research Hospital
- Methods of treating alzheimer's disease by administration of protective protein/cathepsin A26 Jul 2016US 9,399,791 B2St. Jude Children?S Research Hospital
- Adenovirus type 5/3 for detecting circulating tumor cells12 Jun 2025US 2025/0188426 A1Curigin Co., Ltd.
- Methods of treating dementia associated with alzheimer's disease with protective protein/cathepsin a (ppca)22 Dec 2022US 2022/0406435 A1St. Jude Children?S Research Hospital
- Bio-imaging probes and methods for non-invasive detection of human uterine sarcomas12 Aug 2021US 2021/0244832 A1
- Adenovirus control virus2 Jul 2020US 2020/0208173 A1Seracare Life Sciences, Inc.
- Methods of treating dementia associated with alzheimer's disease with protective protein/cathepsin a (ppca)19 Mar 2020US 2020/0087704 A1St. Jude Children?S Research Hospital
Most cited
By later US patents
- Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)1US 10,533,208 B2St. Jude Children?S Research Hospital · 2020
- Methods of treating alzheimer's disease by administration of protective protein/cathepsin A1US 9,399,791 B2St. Jude Children?S Research Hospital · 2016
- Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use1US 9,840,727 B2St. Jude Children?S Research Hospital · 2017